Oncology Institute

The Oncology Institute serves a broad population of cancer patients from central Israel and throughout the country. The fast-track appointment service enables patients to be seen for their initial visit within 48 hours of contacting the institute.

The Oncology Division at Ichilov is one of the leading and most advanced in Israel, combining clinical care at the highest level, groundbreaking research, and national leadership.

  • Dedicated Centers of Excellence for all types of cancer, based on a multidisciplinary approach to care and personalized treatment plans.
  • World-class advanced technology: The Radiotherapy Division at Ichilov is among the most advanced in Israel, with six next-generation linear accelerators enabling precise and targeted treatments.
  • Academic excellence: The division has the largest number of academic professors in the field and serves as a center of knowledge and training for medical teams from across the country.
  • Academic leadership – a breakthrough in cancer care in Israel: Ichilov Hospital has received official recognition for four oncology fellowship programs. For the first time in Israel, four oncology fellowship programs have been officially recognized, offering advanced specialization in colorectal, breast, lung, and urinary tract cancers. The recognition was granted to Tel Aviv Ichilov Medical Center by the Scientific Council of the Israel Medical Association.
  • National Proton Therapy Center: Ichilov has been authorized by the Ministry of Health to serve as the national center for proton therapy – an innovative, targeted treatment method for cancerous tumors.
  • Research leadership: The division has received the highest number of oncology research grants in Israel, reflecting the quality of its research and the innovation driving the field.
  • Nationwide collaboration: As part of its national responsibility, the division supports and mentors Barzilai Medical Center in Ashkelon and Laniado Medical Center in Netanya, helping implement advanced standards of care.

The Oncology Division provides care for all cancer patients from central Israel and other parts of the country, including patients who have not yet been diagnosed but have been referred for further oncological evaluation. The division offers rapid access to an oncologist for an initial consultation within 48 hours, advanced and personalized oncology care, and treatment for all types of cancer and their associated conditions.

The division treats breast cancer, gastrointestinal cancer, sarcoma (bone and soft tissue tumors), lung cancer, melanoma and other skin tumors, genitourinary cancers, gynecological tumors, thyroid cancer, and brain tumors (nervous system tumors).

Oncology Division Units

The Oncology Division operates two hospitalization facilities: an inpatient department, intended for oncology patients at various stages of their disease, and an oncology day hospitalization unit, which enables patients to receive treatment without the need for full hospitalization.

These facilities provide care for patients across all fields of oncology, including tumors of the gastrointestinal tract, brain and nervous system, urinary system, skin tumors and melanoma, breast tumors, bone and soft tissue tumors, gynecologic oncology tumors, and lung and chest tumors.

The inpatient department provides chemotherapy, treatment of complications resulting from chemotherapy or radiation therapy, supportive and palliative care, radioactive iodine therapy, and radiation therapy for patients with limited mobility. Patients in the department can receive a wide range of chemotherapy drugs at no additional cost.

The oncology day hospitalization unit provides chemotherapy, biological therapies, and immunotherapy for patients who do not require full hospitalization, as well as supportive care as needed between treatment cycles.

Most admissions to the inpatient department are planned in advance and scheduled by appointment. When possible, urgent patients are also admitted through the Emergency Department or transferred from other hospital departments.

The department's staff provides warm, personalized care, taking into account the unique needs of each patient. The staff is available to provide patients and their families with information and guidance about the disease and its treatment options.

Inpatient Department
Tel: +972-3-6973815 | Fax: +972-3-6974224

Day Hospitalization Unit
Tel: +972-3-6974575 | Fax: +972-3-6974944 / 4366
oncodaycare@tlvmc.gov.il

Radiation therapy is a central component of cancer treatment. In many cases, it is the primary treatment for the disease, either on its own or in combination with chemotherapy or other treatments.

The Radiation Therapy Institute at Ichilov Hospital is the largest and leading institute in Israel in terms of technology, medical staff, the use of artificial intelligence, and imaging equipment from the world's leading companies. The institute is a member of global development teams for radiation therapy equipment, all with the aim of providing patients with the most advanced treatment.

The institute is part of the Oncology Division, and its medical team consists of leading specialist oncologists with dedicated areas of expertise. Each patient is accompanied by a senior oncologist specializing in their specific medical condition and disease.

Telephone Switchboard
Tel: 03-6973997

Linear Accelerators: 03-6973997, Extension 1

Institute Director’s Secretary
Tel: +972-3-6947285

Appointment Scheduling – Referral Required
Fax: +972-3-6974832
Email: Rdy-c@tlvmc.gov.il

Email for Inquiries and Submission of Referrals for Appointment Scheduling
Rdy-c@tlvmc.gov.il

The Rapid Diagnosis Center aims to shorten and streamline the diagnostic process for patients with a high suspicion of malignancy or a complex disease. The service includes coordination of the medical evaluation, rapid scheduling of laboratory and imaging tests, guidance and support from a nurse coordinator, and referral for appropriate further treatment at Ichilov following diagnosis.

The center is intended for patients with findings that raise significant suspicion of malignancy or a complex disease, including abnormal findings in laboratory tests, imaging studies, endoscopic examinations, or physical examinations. The center is not intended for the initial evaluation of nonspecific symptoms.

The process begins with an inquiry by telephone, WhatsApp, or email, without the need for a physician's referral. Following an initial consultation with a nurse coordinator and a review of the medical information, a personalized diagnostic plan is developed, including rapid scheduling of the required tests, subject to obtaining Form 17 (payment authorization) from the health fund.

Once the test results and diagnosis are received, the patient is referred for appropriate further treatment at Ichilov, with all services provided under one roof.

Rapid diagnosis contributes to accurate treatment at the earliest possible stage, which can improve quality of life, significantly increase the chances of recovery even from serious diseases, and sometimes even save lives.

Phone and WhatsApp Inquiries
+972-3-6972049

Phone Inquiries
Tel: +9723-7772641 | Fax: +972-3-7772625

Email
tasmc-rdunit@tlvmc.gov.il

The Neuro-Oncology Clinic at Ichilov, which operates as part of the Oncology Division, specializes in the treatment and follow-up of patients with tumors of the brain and central nervous system, as well as patients with oncological diseases who suffer from neurological complications.

The clinic treats three main groups of patients:

  • Patients with primary brain and spinal cord tumors – including various types of gliomas and rarer tumors. Treatment includes radiation therapy, chemotherapy, biological therapies, neurological treatment, and follow-up through imaging examinations.

  • Patients with metastases in the central nervous system – patients with metastases in the brain or spine who are referred for evaluation and treatment recommendations and continue joint follow-up with their treating oncologist.

  • Patients with oncological or hemato-oncological diseases who suffer from neurological complications – undergo clinical evaluation and further diagnostic assessment as needed, and receive recommendations for neurological treatment and follow-up alongside their oncological treatment.

Also available via WhatsApp at this number
Tel: +972-3-6947667 | Fax: 073-2447161
Email: onco7-c@tlvmc.gov.il

The Gastrointestinal Cancer Center provides comprehensive care under one roof for patients with a wide range of gastrointestinal cancers, from initial diagnosis and development of a treatment plan, through treatment, to follow-up after recovery.

The center treats colon tumors (the most common type), rectal tumors, anal tumors, esophageal cancer, stomach cancer, pancreatic cancer, small intestine tumors, duodenal tumors, bile duct tumors, gallbladder cancer, liver cancer, gastrointestinal stromal tumors (GIST), and neuroendocrine tumors.

Gastrointestinal tumors account for a significant proportion of all cancer cases. The preferred approach to managing these diseases is multidisciplinary care, placing the patient and their family at the center, surrounded by all the relevant medical specialists.

Maintaining continuity of care for each patient is a fundamental principle of the center's work. Rather than having the treating physician refer patients separately to specialists in different fields, the center proactively schedules patients for joint multidisciplinary clinics.

Clinical trials involving new and experimental drugs are an integral part of the care provided at the center. When evaluating treatment options for each patient, the possibility of participation in one of the clinical trials currently being conducted within the Oncology Division is also considered. Participation in these trials allows patients to receive innovative treatments before they become commercially available, while benefiting from close medical monitoring by a team experienced in clinical research.

Specialized Multidisciplinary Clinics Operating Within the Center at Tel Aviv Medical Center

Combined Clinic for Advanced Hepatoma: During a single visit, patients meet both a gastroenterologist specializing in liver diseases and their treating oncologist.

Combined Oncology-Endocrinology Clinic for Neuroendocrine Tumors: During a single visit, patients meet both an endocrinologist and their treating oncologist. Treatment decisions are made through joint discussions involving leading specialists in the fields relevant to this complex disease.

Combined Oncology-Surgery Clinic for Anal and Rectal Tumors: Operated in collaboration with the proctology team of the Surgical Division, this clinic enables patients to undergo a surgical examination and receive an oncology consultation during a single visit. It also facilitates close collaboration between the oncologists and surgeons involved in their care.

Combined Oncology-Surgery Clinic for Esophageal and Gastric Tumors: Operated in collaboration with the Surgical Division, this clinic enables patients to undergo a surgical examination and receive an oncology consultation during a single visit, facilitating close collaboration between the oncologists and surgeons involved in their care.

Also available via WhatsApp at this number
Tel: +972-3-6973082 | Fax: +972-3-6973029
Email: icr-fax2mail-2002@tlvmc.gov.il

The Uro-Oncology Unit within the Oncology Division at Ichilov provides oncological treatment for patients with prostate, bladder, kidney, and testicular tumors.

The Uro-Oncology Unit's team provides oncological treatment for patients with various malignancies of the urological system, including prostate cancer, urinary tract cancer (renal pelvis, ureter, and bladder), kidney cancer, and testicular cancer (germ cell tumors). The unit's physicians manage the overall care of patients with these tumors, including developing recommendations for treatment and follow-up.

The unit holds regular multidisciplinary meetings attended by physicians from various departments, including Urology, Imaging, Pathology, Nuclear Medicine, and Radiation Oncology. During these meetings, patient cases are presented, and recommendations for treatment and follow-up are formulated.

The Uro-Oncology Unit offers the best established treatments available at leading medical centers worldwide and conducts clinical trials involving new drugs. In addition, the unit's team is involved in training medical students, medical interns, and oncology residents.

Tel: +972-3-6972064 | Fax: +972-3-6973721
Email: onco1-c@tlvmc.gov.il

At the Melanoma and Skin Tumor Center, treatment is provided by a large multidisciplinary team. All physicians are highly regarded specialists in their fields, with extensive experience in treating patients with melanoma and skin tumors.

The treatment of skin cancer, skin tumors, and melanoma is managed by the oncologist at the clinic, in collaboration with senior physicians at Ichilov specializing in surgical oncology, plastic surgery, Mohs surgery, dermatology, radiation oncology, radiology, and pathology, as well as dedicated nurses.

At the Melanoma and Skin Tumor Unit, treatment is provided by a large multidisciplinary team. All physicians are highly regarded specialists in their fields, with extensive experience in treating patients with melanoma and skin tumors.

Most patients are referred by dermatologists or plastic surgeons from community clinics or hospital outpatient clinics following a diagnosis of a skin tumor. In addition, any patient with a current or previous diagnosis of a skin tumor may contact the center to schedule an initial consultation.

Patients who are candidates for surgery are referred to the Combined Melanoma Clinic, where they meet with an oncologist, a surgical oncologist, a plastic surgeon, a dermatologist, and a nurse coordinator to develop a treatment plan.

Patients who require systemic treatment only are invited to a consultation with the oncologist, sometimes together with a senior radiation oncologist, to select the optimal treatment.

Head and neck tumors are unique due to the wide variety of organs in this region, including the larynx, thyroid gland, salivary glands, oral cavity, and others.

These tumors differ in their characteristics and are caused by various factors, including viruses, smoking, alcohol consumption, and others.

They also differ in prognosis and rate of disease progression. For example, thyroid tumors typically have a slow biological course, whereas oral cavity tumors are generally aggressive, with rapid progression and a tendency to recur.

Consequently, treatment approaches also vary and may include surgery, radiation therapy, radiation combined with chemotherapy, biological therapies, and immunotherapy. Another distinguishing feature of tumors in this region is the functional importance of the affected organs, including breathing, swallowing, and speech, as well as their visible location. Therefore, aesthetic considerations are highly significant in treatment and in maintaining patients' quality of life.

The Head and Neck Tumors Unit has an extensive professional multidisciplinary team dedicated to preserving and managing patients' ability to speak, chew, swallow, maintain mouth opening, and other essential functions, with the aim of maintaining their quality of life.

The team includes head and neck surgeons specializing in otolaryngology (ENT), medical oncology specialists, radiation therapy specialists, surgeons specializing in head and neck surgery and swallowing, radiation oncologists, speech-language pathologists, dietitians, psycho-oncology professionals, social workers, and all the support services of the Oncology Division.

WhatsApp Contact
+972-3-6972065

Appointment Scheduling
+972-3-6974000

The Breast Cancer Unit accompanies patients throughout their treatment and recovery journey, from diagnosis through oncological treatment to routine follow-up after treatment completion.

The physicians in the Breast Cancer Unit within the Oncology Division at Ichilov are oncologists specializing in breast cancer. The breast oncologist, together with imaging specialists, surgeons, radiation oncologists, pathologists, and a geneticist, is responsible for developing a personalized treatment plan for each patient.

The multidisciplinary team discusses each patient's medical condition and selects the most appropriate treatment from the available options, including chemotherapy, hormonal therapy, biological therapy, radiation therapy, or a combination of these treatments. The team determines the course of treatment, including coordination and scheduling of its various components.

Throughout treatment, considerable attention is given to providing information and guidance regarding the side effects of the various breast cancer treatments, as well as follow-up examinations, early detection, and breast cancer prevention.

The unit's team includes oncologists specializing in breast cancer treatment and nurse coordinators who manage all treatment-related procedures for patients, coordinate between healthcare providers, and address any problems or questions that arise during treatment.

The unit also offers genetic counseling with a medical geneticist and testing for BRCA1/2 mutations, as well as other cancer-related genetic mutations.

- Chemotherapy for breast cancer: Administered at the Oncology Day Hospitalization Unit according to the treating oncologist's instructions, usually over several hours. The unit has a highly skilled team of physicians and nurses who ensure patients' well-being and professional care. When needed, patients also have access to psychologists, social workers, a sexual health counselor, and supportive care services to alleviate side effects and complications of the disease and its treatment.

- Radiation therapy for breast cancer: Provided at the Radiation Therapy Institute, which is recognized as an international center of excellence. The institute uses advanced, state-of-the-art medical technologies, including sophisticated linear accelerators, precise CT simulation, and more.

Also available via WhatsApp at this number
Tel: +972-3-6972061 | Fax: +972-3-6974789

The Bone and Soft Tissue Oncology Unit (Sarcoma) treats patients with a variety of tumors originating from fat cells, cartilage, muscle, bone, blood vessel walls, nerves, and connective tissue, all belonging to the sarcoma family. These tumors are relatively rare, with an annual incidence of 250–300 new cases in Israel.

The unit works in close collaboration with the Orthopedic Oncology team, which serves as a national referral center for sarcomas. Two multidisciplinary meetings are held each week, involving a pathologist specializing in sarcoma, bone and soft tissue imaging specialists, and nurse coordinators. During these meetings, new and existing patient cases are discussed, and diagnostic or treatment plans are developed.

The unit maintains close working relationships with additional surgical teams, including gynecologic oncology, cardiothoracic surgery, and neurosurgery.

The unit maintains close academic ties with Tel Aviv University, supervises students during clinical rotations, and provides educational lectures for students, family physicians, and oncology residents as part of continuing medical education.

Research is a central part of the unit's activities, encompassing both clinical and laboratory research. The unit presents its work at international conferences and maintains ongoing relationships with other leading centers in Israel and abroad.

Also available via WhatsApp at this number
Tel: +972-3-6972063 | Fax: 073-2447160

The Women's Cancer Unit within the Oncology Division at Tel Aviv Medical Center, Ichilov, treats women diagnosed with or suspected of having gynecologic malignancies involving the uterus, ovaries, cervix, vulva, and vagina.

Treatment is provided through a holistic, multidisciplinary approach, led by the center's oncologists in full collaboration with other healthcare professionals, including gynecologic oncologists (responsible for the surgical aspects of treatment), radiologists, pathologists, nursing staff, social workers, psychologists, the Palliative Care and Pain Management Unit, onco-geriatrics specialists, and the Complementary Medicine Center within the Pain Institute.

The Women's Cancer Unit also works in collaboration with all inpatient departments and the Oncology Day Hospitalization Unit and provides consultations to other hospital departments.

The unit's team is committed to medical excellence and tailoring treatment to each patient's individual needs. Accordingly, in suitable cases, treatment is based on molecular testing, enabling personalized selection of treatment for each patient.

The Women's Cancer Unit is recognized as a medical center of excellence and therefore serves as a national referral center for ovarian cancer. Patients from across Israel are referred to the unit due to its impressive recovery rates, which are above the national average.

In addition, the unit takes pride in offering alternative approaches alongside conventional treatments such as radiation therapy, chemotherapy, and biological therapies, as well as conducting a wide range of research studies, including clinical drug trials and quality research using innovative methods.

As part of Tel Aviv Medical Center, Ichilov, one of the leading international centers for cancer treatment, the Women's Cancer Unit maintains ongoing contact with leading cancer centers worldwide and conducts joint medical consultations as needed.

You can also contact us via WhatsApp at this number
Tel: +972-3-6972062 | Fax: 074-7603757
Email: ONCO4-C@TLVMC.GOV.IL

Palliative (supportive) care is an integral part of the treatment of serious illnesses that are difficult to cure. Coping with the disease, undergoing difficult treatments, and dealing with the changes experienced by patients and their families require special attention and a comprehensive approach from all healthcare providers.

The Palliative Medicine Unit at Ichilov operates under the Geriatrics Division, in close collaboration with the Oncology Division. The unit provides care through an outpatient clinic and a consultation service available throughout the hospital, including the various inpatient departments, thereby ensuring continuity of care.

The unit aims to provide the best and most comprehensive care possible for patients suffering from serious malignant diseases, with particular emphasis on the individual needs of each patient and their family members.

  • Providing support throughout the course of the disease, with an emphasis on maintaining quality of life and preventing suffering.

  • Providing treatment to relieve symptoms such as pain, shortness of breath, depression, weakness, loss of appetite, nausea, and others, which are very common among patients with cancer or other serious illnesses that are difficult to cure, such as heart failure and advanced lung disease.

  • Supporting decision-making and helping patients cope with complications and crises during the course of the disease.

  • Assisting with coordination of community-based services and various interventions designed to support patients and their families.

  • Coordinating care with other hospital professionals, including social workers, psychologists, and physicians from various specialties.

  • Supporting patients and their families at the end of life.

Tel: +972-3-6972955
Email: liatch@tlvmc.gov.il

Over the past decade, extensive clinical research activities have been conducted and managed within the Oncology Division at Ichilov Hospital, in close collaboration with research organizations and pharmaceutical companies in Israel and around the world.

Clinical research in oncology focuses on developing innovative treatments and identifying the optimal treatment for different types and stages of cancer. As part of these studies, patients who volunteer to participate receive medications or undergo innovative medical procedures, after these have been reviewed and approved by the institutional Helsinki Committee and the Ministry of Health.

The research team within the Oncology Division at Ichilov participates in international clinical trials evaluating the efficacy and safety of new drugs, treatments, and medical technologies, in collaboration with leading research organizations worldwide. These studies cover a wide range of cancers, including breast, lung, gastrointestinal, brain, prostate, and kidney cancers, as well as soft tissue sarcomas.

Participation in a clinical trial is voluntary and requires informed consent. After the patient's medical eligibility for the study has been assessed, they receive detailed information about the study's objectives, duration, required treatments and examinations, potential benefits and risks, and available treatment alternatives.

Patients may withdraw from a clinical trial at any stage without affecting their right to receive the best available alternative medical treatment. Clinical trials are conducted in accordance with international and Israeli research regulations and are subject to approval by the Helsinki Committee.

Participation in a clinical trial may provide patients with access to innovative treatments that have not yet become part of standard care, alongside close monitoring and support from a specialized medical team.

However, the effectiveness of the treatments being investigated has not yet been fully established, and they may cause unexpected side effects or require more frequent examinations and monitoring. Participation in clinical research also contributes to advancing medical knowledge and developing future cancer treatments.

Prof. Ravit Geva
Tel: +972-3-6973494
Email: ravitg@tlvmc.gov.il

Katy Doksin
Tel: +972-3-6977833
Email: katyd@tlvmc.gov.il

Lung cancer is one of the most common types of cancer in oncology, with approximately two million patients diagnosed worldwide each year. In recent years, significant advances have been made in the molecular understanding of this disease and in tailoring treatments accordingly.

The unit operates within the Oncology Division at Ichilov and specializes in the treatment of lung cancer and rare thoracic tumors. It treats various types of tumors that differ in their characteristics, risk factors, and disease progression.

Non-Small Cell Lung Cancer (NSCLC) is the most common type, accounting for approximately 85% of lung cancer cases. It includes several subtypes, such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Risk factors include smoking, occupational exposure to certain substances, genetic factors, and age.

Small Cell Lung Cancer (SCLC) accounts for approximately 12% of lung cancer cases, is primarily associated with smoking, and is characterized by rapid tumor cell growth.

In addition, the unit treats malignant mesothelioma, a rare tumor of the pleura that is mainly associated with prolonged exposure to asbestos. It may cause coughing, shortness of breath, chest pain, and fluid accumulation around the lungs.

The unit also treats thymoma and thymic carcinoma, rare tumors that develop in the anterior mediastinum of the chest. In some cases, these tumors are associated with the autoimmune disease myasthenia gravis.

The unit works in close collaboration with the hospital's multidisciplinary lung tumor forum. Weekly meetings are held with the participation of oncologists, radiologists, pulmonologists, cardiothoracic surgeons, and pathologists. During these meetings, new and existing patient cases are discussed, and diagnostic or treatment plans are developed.

The unit also provides services to all hospital departments and clinics, offers consultations for hospitalized patients, and serves as a tertiary referral center for several smaller hospitals.

The unit maintains close academic ties with Tel Aviv University, supervises students during clinical rotations, and provides educational lectures for students, family physicians, and oncology residents as part of continuing medical education.

In addition, the unit is part of the Israeli Lung Cancer Group within the national oncology association and participates in nationwide collaborations.

Research is a central component of the unit's activities, encompassing both clinical and laboratory research. The unit presents its work at international conferences and maintains ongoing relationships with other leading centers in Israel and abroad.

Also available via WhatsApp
Tel: +972-3-6972063 | Fax: 073-2447160

Email: onco6-c@tlvmc.gov.il